Interestingly, radioresistance of KEAP1/NFE2L2 mutated NSCLC cells could be overcome by treatment with a glutaminase inhibitor resulting in depletion of glutathione [14]. Here, NFE2L2 is linked to non-small cell lung carcinoma.